JOURNAL OF MEDICAL AND SURGICAL RESEARCH - Vol. Xl, n 1, June 2024
Pages: 1321-1326
Date of Publication: 30-Jun-2024
Print Article
Download XML Download PDF
The Complications of Totally Implantable Central Venous Access Ports: Results from a Prospective Study in Morocco
Author: Hanane El Oualy, Bekkay Hajji, Mouhsine Omari, Hamid Madani
Category: JMSR Anesthesiology and IC
Abstract:
Background: The purpose of this work is to present a prospective study on the implantation of a totally implantable central venous port system (TICVPS) for chemotherapy patients as well as to assess and compare the complications that have occurred in our department to those reported in the literature. Methods and Materials: The oncology center hosted the study, which involved 100 cancer patients between July 7, 2020, and July 25, 2021, with an average age of 58.4 years. A right subclavian vein percutaneous puncture was the preferred method in the series. Results: The following incidents occurred during device implantation: 1% of accidental arterial puncture hematomas, 2% of failed placements, and 1% of pneumothorax cases (necessity of drainage). The long-term evolution was characterized by obstruction, which accounts for 1% of all placements, infection, 3%, thrombosis, and extravasation, which together account for 1% of all placements. Conclusion: The use of implantable catheters enhances both the patient's and the healthcare team's comfort, but the procedure has complications that can occasionally be dangerous despite its generally benign reputation.
Keywords: Cancer, Complications, Case series, TICVPS, Prospective study, Morocco
References:
- El Oualy, H., Hajji, B., Mellit, A., Omari, M., Ahsayan, K. and Madani, H., 2022, May. Prediction of Port A Cath Complications Using Machine Learning Techniques. In International Conference on Electronic Engineering and Renewable Energy Systems (pp. 317-327). Singapore: Springer Nature Singapore. Doi : 10.1007/978-981-19-6223-3_35.
- Noël-Savina É, Quéré G, Gouva S, Robinet G, Descourt R. Infection et thrombose sur chambre implantable : diagnostic et prise en charge thérapeutique. Bull Cancer 2011 ; 98 : 1107-1118. doi : 10.1684/bdc.2011.1403.
- ALHOMME P, DOUARD MC, LEQUEAU F, BOUDAOUD S, EURIN B. S. Boudaoud, Alhomme P. Abords veineux percutanés chez l'adulte Médecine d’urgence, 25-010-D-10, 2007
- J-Y Lefrant, L Muller, J-E De La Coussaye, M Prudhomme, J Ripart, C Gouzes, P Peray, G Saissi, J-J Eledjam. Risk factors of failure and immediate complication of subclavian vein catheterization in critically ill patients Intensive Care Med. 2002 ; 28(8):1006-8.
- Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1994; 121:72–3.
- El Oualy, H., Hajji, B., Moukhtari, K., Omari, M. and Madani, H., 2023, April. Evaluation of Machine Learning and Ensemble Methods for Complications Related to Port a Cath, In International Conference on Digital Technologies and Applications pp 133–142. Doi: 10.1007/978-3-031-29857-8_14.
- Paoli C, Bassot V, el-Bez M, Corbin M, Boissady MF, Trotoux J, Bonfils P. Cervicofacial cancerology: complications of implantable systems of venous access. Prospective study. Presse Med. 1994 Apr 9;23(14):649-52.
- Boussen H, Mtaallah M, Dhiab T, Khalfallah S, Jerbi G, Hechiche M, Mezlini A, Rahal K, Ben Ayed F. Evaluation of implantable sites in medical oncology in Tunisia - Prospective study of 205 cases. Ann Fr Anesth Reanim. 2001;20(6):509-513.
- El Kabiri H, El Hammoumi M, Traibi A, El Oueriachi F, & Arsalane A. Les
- chambres à cathéters implantables: à propos d’une série de 970 cas. The Pan African Medical Journal, 2012 ;12 :72.
- Talfer S, Conessa C, Hervé S, Roguet E, de Rotalier P, Poncet JL : Complications des chambres à cathéter implantables. Étude rétrospective de 116 cas. Presse Med 2003;32 : 1263- 8.
- Rouzrokh M, Shamsian BS, KhaleghNejad Tabari A, Mahmoodi M, Kouranlo J et al. Totally implantable subpectoral vs subcutaneous port systems in children with malignant diseases. Arch Iran Med. 2009;12(4):389-394
|